Dose Response of Leucine on Muscle Maintenance During Weight Loss
NCT07583875 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92
Last updated 2026-08-18
Summary
The objective of this research is to determine if there is dose response of leucine on muscle maintenance during 4-week of alternate-day fasting (ADF) on blood parameters, body composition, mood and parameters related to appetite in young men with a body mass index of 23kg/m2 and above, whose body mass falls outside of the healthy range for their height (Asian reference point for increased risk of cardiovascular diseases). Participants have no diagnoses of, and are not prescribed medications for, cardiovascular, metabolic, diabetic, lung (except controlled asthma), kidney, or joint health conditions.
To achieve this objective, 100 hundred young men, aged between 21 and 35 years old will be recruited to complete a 4-week ADF programme. The fasting programme starts at 12 midnight and alternates between fasting and feeding days. Each fasting or feeding day is 24 hours in duration. During fasting days, participants abstain from all food and beverages except for ad libitum plain water and other zero-calorie beverages, and a small meal amounting to 25% of daily caloric need. This small meal must be consumed between 12 pm and 2 pm in this study, for standardization to ensure consistency in the total duration of fasting and feeding. During feeding days, participants eat up to approximately 125% of daily caloric need (calculated weekly), with no restriction on meal timing as long as meals are consumed within the 24-hour period. The programme ends after 4 weeks (28 days) of continuous ADF
All food for the 4-week ADF will be provided. Participants will be randomly assigned (double blind) to the amount of leucine in their diet: 0.02, 0.04, 0.06 or 0.08 g/kg body mass per meal for 1 meal/day on fasting days and 3 meals/day on feeding days.
Blood parameters, body mass, height, waist-to-hip ratio, body composition, mood, stress level, and parameters related to eating and appetite will be measured before and after 4-week of ADF.
The investigators hypothesised a dose response in leucine to maintain muscle mass during weight loss.
Conditions
- Overweight and Obese Adults
- BMI >= 23
Interventions
- DIETARY_SUPPLEMENT
-
leucine
0.02g/kg body mass/meal
- DIETARY_SUPPLEMENT
-
leucine
0.04g/kg body mass/meal
- DIETARY_SUPPLEMENT
-
leucine
0.06g/kg body mass/meal
- DIETARY_SUPPLEMENT
-
leucine
0.08g/kg body mass/meal
Sponsors & Collaborators
-
Ministry of Education, Singapore
collaborator OTHER_GOV -
Nanyang Technological University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 35 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-18
- Primary Completion
- 2021-02-11
- Completion
- 2021-02-11
Countries
- Singapore
Study Locations
More Related Trials
-
Effects of Chronic Leucine Supplemetion on Glucose Homeostasis, Body Compositin, Muscle Mass and Strength of Healthy and Young Subjects
NCT01496768 ·Status: SUSPENDED ·Phase: NA
-
Leucine Supplementation in Elderly Men
NCT00807508 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Assess the Effect of Leucine Along With Resistance Exercise on Muscle Strength and Quality of Life in Elders
NCT00929929 ·Status: COMPLETED ·Phase: NA
-
Determining the Muscle Anabolic Properties of Phosphatidic Acid.
NCT03446924 ·Status: COMPLETED ·Phase: NA
-
The Effect of Leucine on Carnitine Transport to Skeletal Muscle
NCT05009654 ·Status: COMPLETED ·Phase: NA
-
Leucine Supplementation and Skeletal Muscle Disuse
NCT01192009 ·Status: COMPLETED ·Phase: NA
-
Effect of Amino Acid on Muscle Damage
NCT03319147 ·Status: COMPLETED ·Phase: NA
-
Modulation of Muscle Protein Metabolism by Essential Amino Acids
NCT01890369 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Leucine on Body Composition and Muscle Characteristics in Elderly, Type 2 Diabetes Patients
NCT00643773 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Carnitine Supplementation and Resistance Training on Skeletal Muscle Function
NCT03907592 ·Status: COMPLETED ·Phase: NA
-
Branched-chain Amino Acids, and Resistance Exercise on Skeletal Muscle Signaling Pathways
NCT01350427 ·Status: COMPLETED ·Phase: NA
-
The Effects of Leucine on Body Weight
NCT00683826 ·Status: COMPLETED ·Phase: NA
-
Evaluate the Effect of Dietary Supplement on Muscle Mass and Physical Performance for Over 50 Years Old People
NCT04229407 ·Status: COMPLETED ·Phase: NA
-
The Effect of Nandrolone Decanoate and Leucine on Muscle Loss
NCT02376309 ·Status: COMPLETED ·Phase: NA
-
Can Supplemental Leucine Offset Disuse-induced Muscle Atrophy?
NCT03762278 ·Status: COMPLETED ·Phase: NA
-
Efficacy of LN18178 in Improving Muscle Strength, Aerobic Capacity and Body Composition in Healthy Young Males
NCT07092722 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Leucine and Beta-hydroxy-beta-methylbutyrate (HMB) as Anabolic Nutrients After 36 Hours of Fasting
NCT01840098 ·Status: COMPLETED ·Phase: NA
-
The Impact of Energy Intake and Short-term Disuse on Muscle Protein Synthesis Rates and Skeletal Muscle Mass in Middle-aged Adults.
NCT04900701 ·Status: COMPLETED ·Phase: NA
-
Effect of Supplementing a Mixed Macronutrient Beverage With Graded Doses of Leucine on Myofibrillar Protein Synthesis
NCT01885429 ·Status: COMPLETED ·Phase: NA
-
Dileucine and Resistance Training Adaptations
NCT06121869 ·Status: COMPLETED ·Phase: NA
-
Modulation of Muscle Protein Synthesis With Diet and Exercise in Old Aged Women
NCT02053441 ·Status: COMPLETED
-
Leucine Co-ingestion and Myofibrillar Protein Synthesis in Older Adults
NCT02371278 ·Status: COMPLETED ·Phase: NA
-
Comparison of Different Weight Loss Diets With Different Protein Content
NCT02277275 ·Status: COMPLETED ·Phase: NA
-
In Vivo and in Vitro Anabolic Potential of Essential Amino Acids Following Resistance Exercise
NCT05754125 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Leucine or Protein Supplementation and Resistance Training
NCT03501628 ·Status: COMPLETED ·Phase: NA